ZOETIS (ZTS, $164.92) was a top loser over the last three months, falling -1 to $164.92 per share. A.I.dvisor analyzed 288 stocks in the Pharmaceuticals: Other Industry for the 3-month period ending May 8, 2024, and found that of them (5) exhibited an Uptrend while of them (4) demonstrated a Downtrend.